Mineralys Therapeutics
MLYS
MLYS
87 hedge funds and large institutions have $303M invested in Mineralys Therapeutics in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 12 closing their positions.
Holders
87
Holders Change
+10
Holders Change %
+12.99%
% of All Funds
1.28%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
23
Increased
36
Reduced
14
Closed
12
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$4K
Top Buyers
| 1 |
CP
1
Catalys Pacific
Tokyo,
Japan
|
$79.1M |
| 2 |
2
Morgan Stanley
New York
|
$9.21M |
| 3 |
BOCH
3
Blue Owl Capital Holdings
New York
|
$4.89M |
| 4 |
4
BlackRock
New York
|
$12M |
| 5 |
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
|
$6.39M |
